Roumell Asset Management, LLC Coll Plant Biotechnologies LTD Transaction History
Roumell Asset Management, LLC
- $51 Million
- Q2 2024
A detailed history of Roumell Asset Management, LLC transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Roumell Asset Management, LLC holds 276,430 shares of CLGN stock, worth $1.02 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
276,430
Previous 315,288
12.32%
Holding current value
$1.02 Million
Previous $1.69 Million
18.56%
% of portfolio
2.69%
Previous 3.45%
Shares
8 transactions
Others Institutions Holding CLGN
# of Institutions
17Shares Held
1.95MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC485KShares$1.78 Million0.21% of portfolio
-
Pinnacle Associates LTD468KShares$1.72 Million0.04% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.71 Million0.63% of portfolio
-
Brown Advisory Inc119KShares$439,6310.0% of portfolio
-
Amh Equity LTD75.6KShares$278,3800.52% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $40.8M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...